(Q33452151)

26 July 2017

Etodolac/cyclodextrin formulations: physicochemical characterization and in vivo pharmacological studies (English)

1 reference

26 July 2017

Agnese Miro

4

0 references

Antonio Calignano

object named as

Antonio Calignano

5

0 references

author name string

Brunella Cappello

1

1 reference

26 July 2017

Clelia di Maio

2

1 reference

26 July 2017

Maria Iervolino

3

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

Drug Development and Industrial Pharmacy

26 July 2017

1 reference

26 July 2017

35

1 reference

26 July 2017

7

1 reference

26 July 2017

877-886

1 reference

Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization

26 July 2017

1 reference

https://api.crossref.org/works/10.1080%2F03639040802680263

Cyclodextrins as pharmaceutical solubilizers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040802680263

Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040802680263

The utility of cyclodextrins for enhancing oral bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040802680263

Etodolac. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040802680263

Anti-inflammatory effects of etodolac: comparison with other non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040802680263

Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040802680263

Enhanced clearance of leukemic lymphocytes in B-cell chronic lymphocytic leukemia with etodolac

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040802680263

Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040802680263

10.1080/03639040802680263

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference